97209650 - PROSPR

Information

  • Trademark
  • 97209650
  • Serial Number
    97209650
  • Filing Date
    January 09, 2022
    2 years ago
  • Transaction Date
    February 17, 2024
    4 months ago
  • Status Date
    February 16, 2024
    4 months ago
  • Published for Opposition Date
    December 27, 2022
    a year ago
  • Location Date
    February 21, 2023
    a year ago
  • Status Code
    731
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    CASTRO, GIANCARLO
  • Law Office Assigned Location Code
    M10
  • Owners
Mark Drawing Code
4000
Mark Identification
PROSPR
Case File Statements
  • GS0051: Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic media for bacteriological cultures; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes; Diagnostic reagents and contrast media for medical use; Diagnostic reagents for medical use; Protein arrays for diagnosing infectious diseases; Protein arrays for diagnosing cancer; Protein arrays for diagnosing chronic diseases; Protein arrays for medical diagnosis purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious diseases; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, allergies; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents; Medical diagnostic reagents for the analysis of body fluids; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Reagents and media for medical and veterinary diagnostic purposes
  • GS0011: Assays and reagents for use in genetic research; Assays for research purposes; Biochemical preparations for scientific purposes; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Biochemical reagents used for non-medical purposes; Biochemicals for in vitro and in vivo scientific use; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research purposes; Biochemicals, namely, polypeptides for in vitro research use; Biochemicals, namely, precursors for in vitro genetic engineering use; Diagnostic preparations for clinical or medical laboratory use; Diagnostic preparations for scientific or research use; Diagnostic preparations for scientific or research use other than for medical use; Diagnostic preparations other than for medical or veterinary purposes; Diagnostic preparations used in science; Diagnostic preparations, other than for medical or veterinary purposes; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for scientific or research use; Diagnostic reagents for scientific use; Protein arrays and nucleotide arrays for scientific and medical research; Protein in raw material form for scientific and medical research; Proteins for the food industry; Proteins for use in manufacture; Catalysts for chemical and biochemical processes; Chemicals for use in the purification of proteins for in vitro use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Enzymes for use in protein hydrolysis; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use
  • GS0101: Apparatus for DNA and RNA testing for medical purposes; Apparatus used in implementing diagnosis tests designed to detect the abnormal prion protein; Diagnostic apparatus for the detection of cancer; Blood testing apparatus, namely, blood collecting tubes; Blood testing apparatus, namely, blood sampling tubes; Flow cytometers for medical diagnostic uses; Genetic testing apparatus for medical purposes; Immunochemical testing apparatus for medical use; Medical diagnostic apparatus for analyzing and measuring electrolytes in the body; Medical diagnostic apparatus for detecting cancer; Medical diagnostic apparatus for testing DNA and RNA samples; Medical diagnostic apparatus for testing for viruses; Medical diagnostic apparatus, analytical apparatus for medical purposes and blood pressure measuring apparatus; Medical diagnostic instruments for the analysis of body fluids; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical diagnostic apparatus for testing protein, antibody biomarkers; Medical diagnostic apparatus for testing phenotypic biomarkers incorporating recorded operating system software; Medical diagnostic apparatus for testing protein binding and interactions incorporating recorded software for kinetic analysis; Medical instruments, namely, biosensors for detecting infectious diseases; Organoleptic diagnostic testing apparatus for medical, dental or cosmetic use; Sample preparation device for medical diagnostic uses
Case File Event Statements
  • 2/17/2024 - 4 months ago
    23 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 2/16/2024 - 4 months ago
    22 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 2/16/2024 - 4 months ago
    21 - SOU EXTENSION 2 FILED Type: EXT2
  • 2/16/2024 - 4 months ago
    20 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 8/19/2023 - 10 months ago
    19 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/17/2023 - 10 months ago
    18 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 8/17/2023 - 10 months ago
    17 - SOU EXTENSION 1 FILED Type: EXT1
  • 8/17/2023 - 10 months ago
    16 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 2/21/2023 - a year ago
    15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 12/27/2022 - a year ago
    14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 12/27/2022 - a year ago
    13 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/7/2022 - a year ago
    12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/21/2022 - a year ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/21/2022 - a year ago
    10 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 11/21/2022 - a year ago
    9 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 11/21/2022 - a year ago
    8 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 11/21/2022 - a year ago
    7 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 5/10/2022 - 2 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 5/10/2022 - 2 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 5/10/2022 - 2 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/3/2022 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/14/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/12/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP